Distributive justice and the arrival of direct-acting antivirals: who should be first in line?

Hepatology. 2011 Jun;53(6):1789-91. doi: 10.1002/hep.24374.
No abstract available

MeSH terms

  • Algorithms
  • Antiviral Agents / therapeutic use*
  • Health Care Rationing / ethics*
  • Hepatitis C / drug therapy*
  • Humans
  • Oligopeptides / therapeutic use
  • Proline / analogs & derivatives
  • Proline / therapeutic use
  • Resource Allocation / ethics*
  • United States
  • United States Food and Drug Administration

Substances

  • Antiviral Agents
  • Oligopeptides
  • telaprevir
  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • Proline